The Metastatic Breast Cancer Conference is currently seeking abstracts for consideration at the annual conference on Oct. 12 – 13, 2017 at Baylor College of Medicine.
“Metastatic breast cancer needs a dedicated, long-term effort to find curative approaches. This conference will bench mark these efforts and create the collaborative research environment that is a prerequisite for progress,” said Dr. Matthew Ellis, a co-founder of the conference, McNair scholar and director of the Lester and Sue Smith Breast Center, a part of the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor.
The 2017 Metastatic Breast Cancer Conference, sponsored by the Breast Cancer Research Foundation, will provide updates on basic science, clinical and survivorship issues that relate to the development, treatment and evolution of metastatic breast cancer. To further understand and effectively treat metastatic disease, collaboration across clinical and research disciplines, as well as among institutions, is essential.
“The gap between clinical and pre-clinical studies has hindered our progress toward curing metastatic breast cancer. The Metastatic Breast Cancer Conference aims to fill this gap by promoting direct discussions and collaborations among patients, clinicians and scientists,” said Dr. Xiang Zhang, McNair scholar and associate professor in the Breast Center at Baylor.
“The conference highlights several major breakthroughs in metastatic breast cancer research and treatment, including genomic heterogeneity, modeling and immunotherapy of metastatic breast cancer, with a clear focus on improving treatment outcomes through better understanding of the molecular basis of metastasis," said Dr. Yibin Kang, president of the Metastasis Research Society and professor of molecular biology at Princeton University.
The conference is jointly provided by Baylor College of Medicine, the Lester and Sue Smith Breast Center at Baylor and Theresa’s Research Foundation, and in collaboration with the Metastasis Research Society and the Metastatic Breast Cancer Alliance, the conference appeals to oncologists, researchers, students, advocates, patients and other healthcare professionals. This event is approved for AMA PRA Category 1 Credits™.
"One major goal of the Metastasis Research Society is to bring together basic scientists, physicians and patient advocates to advance research and treatment development for metastatic cancer. We are therefore very pleased to support the effort of the Theresa's Research Foundation and Baylor College of Medicine in organizing the annual Metastatic Breast Cancer Conference,” Kang added.
For more information about the conference, visit its website. To submit an abstract for consideration, click here. The deadline for abstract submissions is Aug. 14, 2017, at 11:59 pm central time. Theresa’s Research Foundation will be offering travel stipends for selected abstracts.